Compare OPTT & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPTT | BEAT |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Retail: Computer Software & Peripheral Equipment |
| Sector | Utilities | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 82.7M |
| IPO Year | 2007 | 2021 |
| Metric | OPTT | BEAT |
|---|---|---|
| Price | $0.41 | $2.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $1.50 | ★ $6.75 |
| AVG Volume (30 Days) | ★ 12.6M | 2.8M |
| Earning Date | 12-15-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,748,000.00 | N/A |
| Revenue This Year | $70.98 | N/A |
| Revenue Next Year | $106.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.29 | $0.54 |
| 52 Week High | $1.04 | $4.00 |
| Indicator | OPTT | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 45.75 |
| Support Level | $0.29 | $2.23 |
| Resistance Level | $0.55 | $2.60 |
| Average True Range (ATR) | 0.05 | 0.24 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 44.18 | 2.45 |
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.